Company intelligence / Profile preview

Bittium

Oulu, Finland

Ownership: Private
Employees: ~600
Development stage: Other

Overview

Bittium provides CE-marked, clinically validated, globally commercialized medical devices and digital solutions for remote biosignal diagnostics in cardiology, neurology, and sleep medicine, with positive adoption by hospitals, clinics, and service providers across Europe.

Therapeutic areas: NeurologyPulmonologyCardiovascular
Modalities: DeviceSoftwareRemote monitoringWearable diagnostics
Industry: Physiological Monitoring

Partnerships

Cerenion (neuro-analysis, BrainStatus)Technomed (ECG service, Faros)evismo (remote cardiac monitoring, MedicalSuite)ActiveAction (Italian ECG services)

Beyond the preview

Go deeper on Bittium.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bittium.

Explore the full profile